Rayburn West Financial Services’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
9,059
-1,578
-15% -$185K 0.64% 37
2026
Q1
$1.28M Sell
10,637
-507
-5% -$58.5K 0.75% 37
2025
Q4
$1.17M Buy
+11,144
New +$1.05M 0.73% 37

Other funds holding MRK

Rayburn West Financial Services's MRK Position: Q2 2026 in Review

Rayburn West Financial Services reduced its Merck (MRK) stake by 15% in Q2 2026, selling an estimated $185K and leaving 9,059 shares worth $1.16M. The position accounts for 0.64% of the portfolio, ranked #37.

Rayburn West Financial Services first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.28M in Q1 2026. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Rayburn West Financial Services held 9,059 shares of Merck worth $1.16M as of Q2 2026.
  • Rayburn West Financial Services sold 1,578 Merck shares in Q2 2026, an estimated $185K.
  • Merck made up 0.64% of Rayburn West Financial Services's portfolio in Q2 2026, its #37 holding.
  • Rayburn West Financial Services first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • Rayburn West Financial Services's Merck position peaked at $1.28M in Q1 2026.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Rayburn West Financial Services's 13F filing for Q2 2026, filed 7 Aug 2026.